INNOVATIONS SUBMITTED TO THE 2022 CICI FORUM COMPETITION
The Canada-Israel Cardiovascular Innovation Forum held an innovation competition targeting early-stage companies with projects in either cardiovascular devices or digital heart health. Of the applications received, 6 were selected to present their innovation at the May 15th CICI Forum Virtual Event. See the list of presenters and applicants below. Register to attend the event.
Company: Biobeat Technologies Ltd. (Israel)
Applicant: Arik Eisenkraft
Innovation: Remote Cardiac Rehabilitation Using an Advanced Noninvasive Wireless Wearable monitoring platform in High-Risk Heart Failure Patients (view summary of innovation)
Company: Coramaze Technologies Ltd. (Israel)
Applicant: Ido Sadan
Innovation: Tripair- Next Generation Percutaneous Treatment for Heart Failure Patients (view summary of innovation)
Company: PLAKK Inc. (Canada)
Applicant: Kashif Khan
Innovation: Saving Lives One Scan at a Time: An Artificial Intelligence-Powered Ultrasound Analysis Tool to Characterize and Detect Unstable Plaques (view summary of innovation)
Company: RBY Medical (Canada)
Applicant: Bradley Strauss
Innovation: Angioplasty Support Sleeve for Peripheral Arterial Interventions (view summary of innovation)
Company: Selfit Therapist Robot (Israel)
Applicant: Shahar Figelman
Innovation: Selfit Therapist Robot
(view summary of innovation)
Company: VenoVision (Israel)
Applicant: Jonathan Maron
Innovation: Contactless Hemodynamic Monitoring, Capable of Improving Therapeutic Management for Obese Cardiovascular Patients (view summary of innovation)
ATTEND THE 2022 CICI FORUM EVENT
On May 15, 2022 at 12 pm EDT (7 pm IDT), the top rated projects from Israel and Canada will present their pitch. Investors interested in cardiovascular innovations are invited to attend the virtual event and to contact the companies of interest after the presentation. There will be breakout rooms for interested parties to connect with the presenters.
The Keynote Speaker for the May 15th event is Peter J. Fitzgerald, MD, PhD, Professor Emeritus Medicine & Engineering at Stanford University Medical Center; Co-founder and Managing partner at Triventures.